Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Palladium Surges above $2,400. Is It Sustainable?

A new day, a new record in palladium! Is there any stopping it from reaching another high? What’s next in store for the white metal? If you thought gold had a good year, you were wrong. OK, maybe not wrong, but palladium enjoyed larger gains . Just lo...
Arkadiusz Sieron | January 27, 2020 |

Theralase is raising up to $5.3M to complete bladder cancer study

Theralase Technologies is announcing a brokered financing raise for up to C$5.3 million Proceeds of the financing will be used to further the Phase II Non-Muscle Invasive Bladder Cancer (NMIBC) clinical study Ruvidar is designed to destroy solid core tum...
Coreena Robertson | November 6, 2023 |

Imagin Medical Poised for Breakout with Bladder Cancer Detection Device in FDA Approval Process

A new advancement in bladder-related endoscopic surgery is endorsed and de-risked. You don't often hear about it, but bladder cancer is the sixth most common cancer in the U.S., with approximately 80,000 cases reported every year, and some 600,000 Americans living in ...
Streetwise Reports | November 13, 2019 |

Pharmaceutical company treats bladder cancer with new tech

The following is a transcription of the above video, and The Market Herald Canada has edited it for clarity . Theralase Technologies Inc. (TSXV:TLT) , a clinical-stage pharmaceutical company, is currently developing an innovative, research-backed technology for the ...
Ryan Dhillon | January 8, 2024 |

Disruptive Technology Poised to Deliver Significant Advancement in Bladder Cancer Detection

Chris Temple, editor and publisher of The National Investor, explains why he recommends this small-cap as a Buy. Imagin Medical's disruptive technology is poised to deliver the most significant advancement in bladder cancer detection and removal in decades , ma...
Streetwise Reports | January 15, 2020 |

Why This Small-Cap Miner Could Be a 'Once-in-a-Generation Wealth Builder'

I had been familiar with the story and potential of uber micro-cap (a valuation of little more than C$3 million or so for a LONG time!) Omineca Mining and Metals Ltd.'s (OMM:TSX.V; OMMSF:OTCMKTS) for years. But as gold was beginning to percolate and other necessa...
Streetwise Reports | June 24, 2020 |

Buzz on the Bullboards: A recap of recent activity and stocks in focus

Last week witnessed a flurry of stock activity on Bay Street in Toronto and Wall Street in New York, as investors grappled with market volatility and shifting dynamics. After a major sell-off, markets have been on edge, closely monitoring corporate earnings and other key ...
Jonathon Brown | April 25, 2024 |

Is the Stock Market Out of the Woods Now?

Having opened with a sizable gap, stocks scored sizable gains yesterday. The reversal higher makes one think that we’ve seen a bullish turn. And the short-term outlook has certainly turned more to the bullish side of the spectrum. Let’s assess w...
Monica Kingsley | February 7, 2020 |

Technical Analyst Update on Black Tusk Resources

Technical analyst Clive Maund charts the explorer and discusses recent trading in the stock. Although our buying towards the end of May didn't succeed in triggering a breakout by Black Tusk Resources Inc. (TUSK:CSE; BTKRF:OTCMKTS; 0NB:FSE) , it rose a bit and it...
Streetwise Reports | June 16, 2020 |

2020 – A Close Look At What To Expect

Quite a bit has changed in the global markets and future expectations over the past 4+ weeks. Q4 2019 ended with a bang. US/China Trade Deal, US signing the USMCA Continental Free Trade Agreement, BREXIT and now the Wuhan Virus. On top of all of that, we've learned that German...
Chris Vermeulen | February 11, 2020 |
1 2 3 4 5 6 7 8 9 10 ...